Skip to content

Clinical trials

Duodenal Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Duodenal Neoplasms Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20061
20112
20132
20171
20221
20232
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status4
Recruiting3
Terminated3
Completed1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)2
Weill Medical College of Cornell University2
AdventHealth1
Florida Hospital Tampa Bay Division1
Masonic Cancer Center, University of Minnesota1
Stony Brook University1
Thomas Jefferson University1
University of Illinois at Chicago1
University of Nebraska1
University of Southern California1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Duodenal Neoplasms13
Pancreatic Neoplasms10
Esophageal Neoplasms4
Stomach Neoplasms4
Bile Duct Neoplasms3
Colorectal Neoplasms3
Adenomatous Polyposis Coli2
Cholangiocarcinoma2
Colonic Neoplasms2
Gastrointestinal Diseases2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.